The Role and Mechanism of LncRNA-p21 in Regulating Gastric Cancer Metastasis by Mediating Wnt/β-Catenin Signaling Pathway
Download PDF


Wnt/beta-catenin signaling pathway
Gastric cancer



Submitted : 2023-05-01
Accepted : 2023-05-16
Published : 2023-05-31


Objective: To study the mechanism of lncRNA p21 inhibiting the growth and metastasis of human gastric cancer SGC7901/GES-1 cells by mediating the Wnt/β-catenin signaling pathway. Methods: Lentiviral overexpression of lncRNA-p21 in human gastric cancer SGC7901/GES-1 cell transfections was observed and analyzed for in vitro migration, invasion, cell morphology and proliferation. Besides. Wnt/β-catenin signaling pathway was tested for direct involvement in lncRNA-p21-mediated inhibition of gastric cancer cell growth and proliferation. Wnt/β-catenin signaling pathway was validated using Li-C1. Results: Gastric cancer SGC7901/GES-1 cells in the overexpression of lncRNA-p21 showed changes in stellate morphology, low invasion, or spindle-shaped morphology. LncRNA-p21 inhibited the growth and proliferation of gastric cancer SGC7901/GES-1 cells both in vivo and in vitro, and Wnt/β-catenin signaling pathway mediated the proliferation, invasion, and migration of lncRNA-p21 on gastric cancer SGC7901/GES-1 cells. Conclusion: LncRNA-p21 can inhibit the growth and metastasis of gastric cancer SGC7901/GES-1 cells in vitro and in vivo, and the inhibition of lncRNA p21 is mainly mediated by inhibiting the Wnt/β-catenin signaling pathway.


Ruan X, Huang Y, Weng Y, et al, 2022, Exploration on the Preliminary Mechanism of p21 Regulating POLD1 Gene in Gastric Cancer. Journal of Clinical and Experimental Pathology, 38(04): 404–409.

Lu C, Yuan S, Wu Y, 2021, Mechanism of FoxF1 and FoxF2 Transcription Factors Regulating Energy Metabolism in Early Gastric Cancer by Inhibiting p21Cip1CDK. Journal of Clinical and Experimental Medicine, 20(03): 245–248.

Zhao Y, 2019, Research on Annexin A7 Regulating the Proliferation of Gastric Cancer Cells Through the p21-cyclin/CDK-PCNA-E2F Signaling Axis, dissertation, Chengde Medical College.

Lin Z, 2017, The Role of HoxC10 in Gastric Cancer and its Molecular Mechanism of Transcriptional Regulation of p21, dissertation, Zhejiang University.

Wang X, Guo W, 2014, Bmi-1 Regulates the Stem Cell-Like Characteristics of Gastric Cancer Through miR-21. Proceedings of the 9th National Gastric Cancer Academic Conference and the 2nd Sunshine Great Wall Cancer Academic Conference, 56–57.

Luo X, 2012, The Expression of SCF-E3 Ubiquitination Ligase Subunit ROC1 in Gastric Cancer and its Regulation on the Growth of Gastric Cancer Cells, dissertation, Fudan University.

Ruan X, 2012, Expression of P125 in Gastric Cancer Tissue and Regulation of POLD1 Expression by p21 in Gastric Cancer Cells, dissertation, Guangxi Medical University.

Ruan X, Li Y, Wu Q, et al., 2011, p21 Inhibits the Proliferation of Gastric Cancer SGC7901/GES-1 and Regulates the Expression of POLD1. World Chinese Journal of Digestion, 19(19): 1990–1995.

Li H, Geng M, 2008, Advances in Research on the Relationship Between Cell Cycle Regulatory Factors p21 and CyclinD1 and Gastric Cancer. Journal of Diagnostic Pathology, 2008(02): 154–156.

Li X, 2001, Effects of Xiaotan Sanjie Recipe on Gastric Cancer Cell Cycle Regulation System and Serum Tumor Markers. Second Military Medical University.

Huang R, Zhang J, 2010, Expression and Clinical Significance of Mouse Doubled Microgenes, P53 and P21 in Gastric Cancer Tissue. Journal of Nantong University, 30(3): 177–180.

Zhang F, Li B, 2010, The Clinical Significance of p21 Expression in Esophageal Squamous Cell Carcinoma and Benign Hyperplastic Lesions of Esophageal Squamous Epithelium. Clinical Medicine, 35(4): 372–376.

Ding HL, Qin Z, Sun KH, et al., 2014, Differential Expression of Notch1 Intracellular Domain and P21proteins, and Their Clinical Significance in Gastric Cancer. Oncology Letters, 7: 471–478.

Gu X, Zhu H, Chen J, et al., 2013, Expression and Significance of p27 Protein and Cyclin D1 in Verrucous Gastritis and Gastric Cancer Tissues. Gastroenterology, 18(10): 591–595.

Hu Z, Wei S, Tan M, et al., 2013, Discussion on the Clinicopathological Relationship of p21, HER2, EGFR Expression in Gastric Adenocarcinoma. International Medicine and Health Herald, 19(21): 3263–3268.